A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Baquiloprim | Baquiloprim. Group: Biochemicals. Grades: Highly Purified. CAS No. 102280-35-3. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C17H20N6. US Biological Life Sciences. |  Worldwide |
| Baquiloprim | Baquiloprim, an antibiotic, is a selective inhibitor of bacterial dihydrofolate reductases. Baquiloprim possesses in vitro bacteriostatic activity against both Gram-negative and Gram-positive bacteria[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 102280-35-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-19581. |  |
| Baquiloprim-[d6] | Baquiloprim-[d6] is the labelled analogue of Baquiloprim. Baquiloprim is an antifolate that can be used as an antibacterial. Synonyms: Baquiloprim-D6; 5-(8-Dimethylamino-D6-7-methylquinolin-5-ylmethyl)-pyrimidine-2,4-diamine. Grade: 95% by HPLC; 98% atom D. CAS No. 1228182-50-0. Molecular formula: C17H14D6N6. Mole weight: 314.42. |  |
| Baquiloprim Impurity 1 | Baquiloprim Impurity 1. Uses: For analytical and research use. CAS No. 1228182-50-0. Molecular formula: C17H14D6N6. Mole weight: 314.43. Catalog: APB1228182500. |  |
| Baquiloprim Impurity 2 | Baquiloprim Impurity 2. Uses: For analytical and research use. CAS No. 1608116-38-6. Molecular formula: C17H16Cl2N4. Mole weight: 347.24. Catalog: APB1608116386. | |
| Baquiloprim Impurity 3 | Baquiloprim Impurity 3. Uses: For analytical and research use. CAS No. 83028-30-2. Molecular formula: C17H18N4O2. Mole weight: 310.36. Catalog: APB83028302. | |
| Baquiloprim Impurity 4 | Baquiloprim Impurity 4. Uses: For analytical and research use. CAS No. 83028-27-7. Molecular formula: C15H14N4O2. Mole weight: 282.3. Catalog: APB83028277. | |
| BAR501 | BAR501 is a potent and selective agonist of GPBAR1 with an EC50 of 1 μM. Uses: Scientific research. Category: Signaling pathways. CAS No. 1632118-69-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-101274. | |
| BAR-501 | BAR-501, a UDCA derivative, is a selective GPBAR1 agonist devoid of any FXR agonistic activity. BAR-501 effectively transactivates GPBAR1 in HEK293 cells overexpressing a CRE along with GPBAR1, with a EC50 of 1 μM. Besides, it protects against development of portal hypertension in rodent models of liver injury and endothelial dysfunction. Synonyms: 3R,5S,6S,7S,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol; BAR-501; BAR 501; BAR501. CAS No. 1632118-69-4. Molecular formula: C26H46O3. Mole weight: 406.651. | |
| BAR502 | BAR502 is a dual FXR and GPBAR1 agonist (IC50= 2 μM and 0.4 μM for FXR and GPBAR1, respectively). Synonyms: BAR-502; BAR 502; BAR502; (5S,8S,9R,10S,13R,14S,17R)-6-ethyl-17-(4-hydroxybutan-2-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol. CAS No. 1612191-86-2. Molecular formula: C25H44O3. Mole weight: 392.62. | |
| Barasertib | Barasertib (AZD1152), a pro-drug of Barasertib-hQPA, is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib (AZD1152) induces growth arrest and apoptosis in cancer cells[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AZD1152. CAS No. 722543-31-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10127. | |
| Barasertib | Barasertib is an orally bioavailable, small-molecule, dihydrogen phosphate prodrug of the pyrazoloquinazoline Aurora kinase inhibitor AZD1152-hydroxyquinazoline pyrazol anilide (AZD1152-HQPA) with potential antineoplastic activity. Synonyms: AZD1152; AZD-1152; AZD 1152; Barasertib. CAS No. 722543-31-9. Molecular formula: C26H31FN7O6P. Mole weight: 587.54. | |
| Barasertib | Barasertib. Group: Biochemicals. Alternative Names: AZD1152-HQPA. Grades: Highly Purified. CAS No. 722544-51-6. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C26H30FN7O3. US Biological Life Sciences. | Worldwide |
| Barasertib-HQPA | Barasertib-HQPA (AZD2811) is a highly selective Aurora B inhibitor with an IC50 of 0.37 nM in a cell-free assay. Barasertib-HQPA (AZD2811) induces growth arrest and apoptosis in cancer cells[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AZD2811; INH-34; AZD1152-HQPA. CAS No. 722544-51-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10126. | |
| Barasertib-HQPA (AZD2811) | Defosbarasertib (AZD1152-HQPA, AZD2811, INH-34, Barasertib-HQPA) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM in a cell-free assay, ~3700 fold more selective for Aurora B over Aurora A. Phase 1. Group: Inhibitors. Alternative Names: AZD2811, INH-34, Barasertib-HQPA , Defosbarasertib. CAS No. 722544-51-6. Pack Sizes: 5mg. Product ID: S1147. Formula: C26H30FN7O3. Smiles: CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO. Storage Conditions: 2 years -80 in solvent. |  United States; Europe |
| Barbadin | Barbadin is a novel and selective β-arrestin/β2-adaptin interaction inhibitor, has IC50 values of 19.1 μM for β-arrestin1 and 15.6 μM for β-arrestin2. Barbadin blocks agonist-promoted endocytosis of the prototypical β2-adrenergic, V2-vasopressin and angiotensin-II type-1 receptors. Barbadin can induce apoptosis[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 356568-70-2. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-119706. | |
| Barbadin | Barbadin is a selective β-arrestin/β2-adaptin interaction inhibitor. It blocks agonist-promoted endocytosis of the prototypical β2-adrenergic (β2AR), V2-vasopressin (V2R) and angiotensin-II type-1 (AT1R) receptors, but does not affect β-arrestin-independent (transferrin) or AP2-independent (endothelin-A) receptor internalization. Synonyms: 3-Amino-5-(4-benzylphenyl)thieno[2,3-d]pyrimidin-4(3H)-one. Grade: 99%. CAS No. 356568-70-2. Molecular formula: C19H15N3OS. Mole weight: 333.41. | |
| Barbamide | Barbamide is produced by the strain of Lyn-gbya majiuscula. It has the activity of killing mollusks. Synonyms: CHEBI:80028. Molecular formula: C20H23Cl3N2O2S. Mole weight: 461.83. | |
| Barbatic acid | Barbatic acid is a substance obtained from Cladia aggregata (lichen), which exhibits schistosomiasis effect on adult Schistosoma mansoni. CAS No. 17636-16-7. Molecular formula: C19H20O7. Mole weight: 360.36. | |
| Barberry Extract | Barberry Extract. Applications: Used for health care products, dietary supplements, herb medecine to antihistamine and anti-allergy. Group: Others. Synonyms: Barberry Extract; 117-74-8; Berberis vulgaris L. CAS No. 117-74-8. Purity: 60% Berberine by HPLC. Appearance: Yellowish fine powder. Storage: 2 years under well storage situation and stored away from direct sun light. Source: Bark. Species: Berberis vulgaris L. Barberry Extract; 117-74-8; Berberis vulgaris L.; plant extract. Pack: 25KG/Drum with double plastic bag of foodstuff inside. Cat No: EXTW-127. |  |
| Barberry Root Bark Powde | Barberry Root Bark Powde. |  CA, FL & NJ |
| Barbital | Barbital. Group: Biochemicals. Alternative Names: 5,5-Diethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5,5-Diethyl-barbituric acid; 5,5-Diethylbarbituric acid. Grades: Purified. CAS No. 57-44-3. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C8H12N2O3. US Biological Life Sciences. | Worldwide |
| Barbital (BSA) | Barbiturates are a class of around 12 compounds derivatized from barbituric acid. They are central nervous system (CNS) depressants and can be used as sedatives, hypnotics, anaesthetics and anti-epileptic drugs. Barbiturates can be divided into three main groups according to their duration of action. The ultra-short-acting barbiturates are used clinically as anaesthetics while the long-acting barbiturates have anti-convulsant properties. The short-acting compounds are typically used as hypnotics. The short-acting barbiturates are extensively metabolised by the liver to more pharmacologically inactive hydroxylated compounds. Only a small proportion of parent compound (<0.2%) appears in the urine collected after 24 hours. However, with large doses, there is usually sufficient of the parent compound present to give an adequate response and some of the hydroxylated metabolites will also crossreact in immunoassays. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| barbiturase | Contains zinc and is specific for barbiturate as substrate. Forms part of the oxidative pyrimidine-degrading pathway in some microorganisms, along with EC 1.17.99.4 (uracil/thymine dehydrogenase) and EC 3.5.1.95 (N-malonylurea hydrolase). It was previously thought that the end-products of the reaction were malonate and urea but this has since been disproved. May be involved in the regulation of pyrimidine metabolism, along with EC 2.4.2.9, uracil phosphoribosyltransferase. Group: Enzymes. Enzyme Commission Number: EC 3.5.2.1. CAS No. 9025-16-5. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4492; barbiturase; EC 3.5.2.1; 9025-16-5. Cat No: EXWM-4492. | |
| Barbituric acid | Barbituric acid (BA) may be used in the preparation of the corresponding hemiaminals, via chemoselective reduction in the presence of SmI2/H2O reagent. It may be used in the preparation of BA- modified conjugated carbon nitride nanosheets. Barbituric acid is a useful acid for organic and drug syntheses. Its dihydrate form can be synthesized from barbituric acid via crystallization from aqueous solution. Crystal structure of barbituric acid (in tautomeric form) has been investigated by a three dimensional fourier transform method. Its enol crystal form has been reported to be thermodynamically stable. Group: Biochemicals. Alternative Names: 2,4,6(1H,3H,5H)-Pyrimidinetrione; 1,2,3,4,5,6-Hexahydro-2,4,6-pyrimidinetrione; 2,4,6-Pyrimidinetriol; 2,4,6-Pyrimidinetrione; 2,4,6-Trihydroxypyrimidine; 2, 4, 6-Trioxohexa hydropyrimidine; 6-Hydroxyuracil; Hexahydropyrimidine-2,4,6-trione; Malonylurea; NSC 7889; Fluorouracil. Grades: Purified. CAS No. 67-52-7. Pack Sizes: 100g, 500g. US Biological Life Sciences. | Worldwide |
| Barbituric Acid-13C,15N2 | Parent compound of barbiturate drugs. Synonyms: 2,4,6(1H,3H,5H)-Pyrimidinetrione-13C,15N2; 1,2,3,4,5,6-Hexahydro-2,4,6-pyrimidinetrione-13C,15N2; 2,4,6-Pyrimidinetriol-13C,15N2; 2,4,6-Pyrimidinetrione-13C,15N2; 2,4,6-Trihydroxypyrimidine-13C,15N2; 2,4,6-Trioxohexahydropyrimidine-13C,15N2; 6-Hydroxyuracil-13C,15N2; Hexahydropyrimidine-2,4,6-trione-13C,15N2; Malonylurea-13C,15N2; NSC 7889-13C,15N2. CAS No. 1329809-18-8. Molecular formula: C3[13C]H4[15N]2O3. Mole weight: 131.07. | |
| Barbituric Acid Impurity 1 | Barbituric Acid Impurity 1. Uses: For analytical and research use. Alternative Names: 5-allyl-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione. CAS No. 94154-89-9. Molecular formula: C9H12N2O3. Mole weight: 196.2. Catalog: APB94154899. | |
| Bardoxolone | Bardoxolone is a synthetic oleanane triterpenoid that exerts multifunctional activities in the control of cellular growth and differentiation. Bardoxolone is capable of activating the transcription factor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPARγ. Bardoxolone was developed as an potential drug for the improvement of hyperglycemia, proteinuria, glomerulus structure, serum creatine, which may in turn be beneficial to treat diabetic kidney diseases, cancer and thromboembolic events. Synonyms: CDDO; RTA 401; RTA401; RTA-401. Grade: >98%. CAS No. 218600-44-3. Molecular formula: C31H41NO4. Mole weight: 491.66. | |
| Bardoxolone | Bardoxolone (CDDO; RTA 401) is a Nrf2 activator. Bardoxolone shows anti-SARS-CoV-2 3CLpro with IC50 of 27.99 μM. Bardoxolone activates the Nrf2 pathway and inhibits the NF-κB pathway. Bardoxolone can induce cells differentiation, apoptosis and shows antiproliferative activity against cancer cells. Bardoxolone can increase ROS and decrease intracellular GSH levels. Bardoxolone inhibits Z-VAD-FMK (HY-16658B)-induced necroptosis. Bardoxolone can be used for the research of cancer, inflammation and infection, such as SARS-CoV infection and glioblastoma[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CDDO; RTA 401. CAS No. 218600-44-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14909. | |
| Bardoxolone | Bardoxolone. Group: Biochemicals. Grades: Highly Purified. CAS No. 218600-44-3. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Bardoxolone methyl | Bardoxolone methyl (also known as "RTA 402" and "CDDO-methyl ester") is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. It is the most potent known inducer of the Nrf2 pathway to enter clinical development and works to suppress both oxidative stress and inflammation. Uses: Bardoxolone methyl, also known as rta 402, is a semisynthetic derivative of oleanolic acid that has attracted much attention in the medical community for its potential to treat a variety of chronic diseases, especially chronic kidney disease (ckd). as a member of the antioxidant inflammatory modulator (aim) class of drugs, bardoxolone methyl exerts its therapeutic effects by targeting inflammation. Synonyms: CDDO Methyl ester; CDDOMe; RTA 402; RTA-402; RTA402; TP-155; TP155; TP 155; 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid methyl ester; bardoxolone methyl; CDDO-Me; methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate; (4aS,6aR,6bS,8aR,12aS,14bS)-Methyl 11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate. Grade: ≥ 98.0%. CAS No. 218600-53-4. Molecular formula: C32H43NO4. Mole weight: 505.70. | |
| Bardoxolone methyl | Bardoxolone methyl. Group: Biochemicals. Alternative Names: CDDO-methyl ester. Grades: Highly Purified. CAS No. 218600-53-4. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C32H43NO4. US Biological Life Sciences. | Worldwide |
| Bardoxolone methyl | Bardoxolone (CDDO; RTA 401) methyl is an orally active and blood-brain-barrier-penetrant activator of Nrf2 and an inhibitor of SARS-CoV-2 3CL protease. Bardoxolone methyl inhibits SARS-CoV-2 replication in Vero cells with an EC50 value of 0.29 μM. Bardoxolone methyl increases levels of pNrf2 and HO-1, inhibits inflammatory mediators like pNFκB and MCP-1. Bardoxolone methyl activates the Nrf2 pathway to enhance antioxidant and anti-inflammatory responses, inhibits viral replication, and improves mitochondrial function. Bardoxolone methyl can be used in research on chemotherapy-induced neuropathic pain (CINP), COVID-19, and chronic kidney disease (CKD)[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RTA 402; NSC 713200; CDDO Methyl ester. CAS No. 218600-53-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-13324. | |
| Bardoxolone Methyl (RTA 402) | Bardoxolone Methyl (RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me) is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities; Also a potent Nrf2 activator and nuclear factor-κB (NF-κB) inhibitor. Bardoxolone Methyl abrogates ferroptosis. Bardoxolone methyl induces apoptosis and autophagy in cancer cells. Group: Inhibitors. Alternative Names: RTA 402, TP-155, NSC 713200, CDDO Methyl Ester, CDDO-Me. CAS No. 218600-53-4. Pack Sizes: 25mg. Product ID: S8078. Formula: C32H43NO4. Smiles: CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C. Storage Conditions: 2 years -80 in solvent. | United States; Europe |
| BARETab PH | BARETab PH. Medium particle size, BARETab PH is a high functionality homogeneous co-processed compound composed of binder, glidant, disintegrant, and lubricant. The unique co-processing technology confers superior flowability, compaction, lubricity, disintegration, stability, and content uniformity. The performance of BARETab PH is superior compared to the individual excipients or their simple physical mix. Dosage Form: Tablet. Functionality: Multifunctional, Binder, Glidant, Lubricant, Disintegrant, Natural Origin, Tablet Compressibility. Process: Direct Compression. Particle Size: 120 Microns. |  Sigachi US Inc |
| BARETab TM PH | BARETab TM PH. Medium particle size, BARETabTM PH is a high functionality homogeneous co-processed compound compose of binder, glidant, disintegrant and lubricant. CO-processing makes the product superior in flowability, compaction, lubricity, disintegration, stability and content uniformity. BARETab PH performance is superior compared to the individual excipients or their physical mixing. Dosage Form: Tablet. Functionality: Multifunctional, Binder, Glidant, Lubricant, Disintegrant, Natural Origin, Tablet Compressibility. Process: Direct Compression. Particle Size: 120 Microns. | Sigachi US Inc |
| Bar I | One unit of the enzyme is the amount required to hydrolyze 1 μg of T7 DNA in 1 hour at 37°C in a total reaction volume of 50 μl. Applications: After 2-fold overdigestion with enzyme 90% of dna fragments can be ligated. of these 95% can be recut. Group: Restriction Enzymes. Purity: 100U; 500U. ↑(N)7GAAGNNNNNNTAC(N)12↑ ↓(N)12CTTCNNNNNNATG(N)7&darr. Activity: 500-2000 500-2000u.a./ml. Appearance: 10 X SE-buffer 2K. Storage: -20°C. Form: Liquid. Source: Bacillus sphaericus. Pack: 20 mM KH2PO4(pH 7.4); 100 mM KCl; 0,1 mM EDTA; 7 mM 2-mercaptoethanol; 200 μg/ml BSA, 50% glycerol. Cat No: ET-1031RE. | |
| Baricitinib | Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively. Uses: Scientific research. Category: Signaling pathways. Alternative Names: LY3009104; INCB028050. CAS No. 1187594-09-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-15315. | |
| Baricitinib | Baricitinib. Group: Biochemicals. Alternative Names: INCB 028050; LY 3009104; 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile. Grades: Highly Purified. CAS No. 1187594-09-7. Pack Sizes: 5mg. Molecular Formula: C16H17N7O2S, Molecular Weight: 371.42. US Biological Life Sciences. | Worldwide |
| Baricitinib | Baricitinib Inhibitor. Uses: Scientific use. Product Category: T2485. CAS No. 1187594-09-7. |  |
| Baricitinib | Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). Uses: The treatment of rheumatoid arthritis (ra). Synonyms: LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant. Grade: >98%. CAS No. 1187594-09-7. Molecular formula: C16H17N7O2S. Mole weight: 371.419. | |
| Baricitinib | Baricitinib. Alternative Names: 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile. CAS No. 1187594-09-7. Purity: 98%. Product ID: ACM1187594097. Molecular formula: C16H17N7O2S. Mole weight: 371.42. IUPAC Name: 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile. Canonical SMILES: CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Baricitinib impurity 10 | Baricitinib impurity 10. Uses: For analytical and research use. CAS No. 2166596-69-4. Molecular formula: C12H19N3O2Si. Mole weight: 265.39. Catalog: APB2166596694. | |
| Baricitinib Impurity 10 | Baricitinib Impurity 10. Uses: For analytical and research use. Alternative Names: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole. CAS No. 1029716-44-6. Molecular formula: C13H23BN2O3. Mole weight: 266.14. Catalog: APB1029716446. | |
| Baricitinib impurity 11 | Baricitinib impurity 11. Uses: For analytical and research use. Molecular formula: C12H17Cl2N3OSi. Mole weight: 318.27. Catalog: APB11262. | |
| Baricitinib Impurity 11 | Baricitinib Impurity 11. Uses: For analytical and research use. Alternative Names: (1-(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid. CAS No. 2227194-01-4. Molecular formula: C7H13BN2O3. Mole weight: 184.00. Catalog: APB2227194014. | |
| Baricitinib impurity 12 | Baricitinib impurity 12. Uses: For analytical and research use. CAS No. 894807-98-8. Molecular formula: C15H29BN2O3Si. Mole weight: 324.3. Catalog: APB894807988. | |
| Baricitinib Impurity 12 | Baricitinib Impurity 12. Uses: For analytical and research use. Alternative Names: 4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine. CAS No. 1911644-33-1. Molecular formula: C13H15N5O. Mole weight: 257.29. Catalog: APB1911644331. | |
| Baricitinib Impurity 13 | Baricitinib Impurity 13. Uses: For analytical and research use. Alternative Names: (4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methanol. CAS No. 2761352-71-8. Molecular formula: C14H17N5O2. Mole weight: 287.32. Catalog: APB2761352718. | |
| Baricitinib impurity 14 | Baricitinib impurity 14. Uses: For analytical and research use. Molecular formula: C17H21N7O4S. Mole weight: 419.46. Catalog: APB11263. | |
| Baricitinib Impurity 14 | Baricitinib Impurity 14. Uses: For analytical and research use. Alternative Names: 4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine. CAS No. 952518-97-7. Molecular formula: C9H7N5. Mole weight: 185.19. Catalog: APB952518977. | |
| Baricitinib Impurity 15 | Baricitinib Impurity 15. Uses: For analytical and research use. Alternative Names: (4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methanol. Molecular formula: C10H9N5O. Mole weight: 215.21. Catalog: APB03631. | |
| Baricitinib impurity 16 | Baricitinib impurity 16. Uses: For analytical and research use. Molecular formula: C15H15N7O. Mole weight: 309.33. Catalog: APB11264. | |
| Baricitinib Impurity 16 | Baricitinib Impurity 16. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. CAS No. 2402776-84-3. Molecular formula: C23H27N9O4S2. Mole weight: 557.65. Catalog: APB2402776843. | |
| Baricitinib Impurity 17 | Baricitinib Impurity 17. Uses: For analytical and research use. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetamide. Molecular formula: C22H33N7O4SSi. Mole weight: 519.69. Catalog: APB03629. | |
| Baricitinib Impurity 18 | Baricitinib Impurity 18. Uses: For analytical and research use. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Molecular formula: C22H31N7O3SSi. Mole weight: 501.68. Catalog: APB03630. | |
| Baricitinib impurity 19 | Baricitinib impurity 19. Uses: For analytical and research use. Molecular formula: C7H7N3O2. Mole weight: 165.15. Catalog: APB11265. | |
| Baricitinib Impurity 19 | Baricitinib Impurity 19. Uses: For analytical and research use. Alternative Names: methyl 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetate. CAS No. 2402776-80-9. Molecular formula: C17H20N6O4S. Mole weight: 404.44. Catalog: APB2402776809. | |
| Baricitinib impurity 20 | Baricitinib impurity 20. Uses: For analytical and research use. Molecular formula: C19H21N7O2. Mole weight: 379.42. Catalog: APB11266. | |
| Baricitinib Impurity 20 | Baricitinib Impurity 20. Uses: For analytical and research use. Alternative Names: 1-(3-aminopropyl)azepan-2-one. CAS No. 24566-95-8. Molecular formula: C9H18N2O. Mole weight: 170.25. Catalog: APB24566958. | |
| Baricitinib Impurity 21 | Baricitinib Impurity 21. Uses: For analytical and research use. Alternative Names: tert-butyl 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(cyanomethyl)azetidine-1-carboxylate. CAS No. 1269823-19-9. Molecular formula: C19H21N7O2. Mole weight: 379.42. Catalog: APB1269823199. | |
| Baricitinib Impurity 22 | Baricitinib Impurity 22. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. CAS No. 1187594-16-6. Molecular formula: C14H13N7. Mole weight: 279.30. Catalog: APB1187594166. | |
| Baricitinib Impurity 23 | Baricitinib Impurity 23. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. Molecular formula: C22H20N10O2S. Mole weight: 488.53. Catalog: APB03616. | |
| Baricitinib impurity 24 | Baricitinib impurity 24. Uses: For analytical and research use. CAS No. 1153949-11-1. Molecular formula: C10H14N2O2. Mole weight: 194.23. Catalog: APB1153949111. | |
| Baricitinib Impurity 24 | Baricitinib Impurity 24. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(propylsulfonyl)azetidin-3-yl)acetonitrile. CAS No. 1187594-34-8. Molecular formula: C17H19N7O2S. Mole weight: 385.44. Catalog: APB1187594348. | |
| Baricitinib impurity 25 | Baricitinib impurity 25. Uses: For analytical and research use. CAS No. 1401222-91-0. Molecular formula: C5H9NO3S. Mole weight: 163.19. Catalog: APB1401222910. | |
| Baricitinib Impurity 25 | Baricitinib Impurity 25. Uses: For analytical and research use. Alternative Names: 2-(1-(ethylsulfonyl)-3-(4-(7-(ethylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile. Molecular formula: C18H21N7O4S2. Mole weight: 463.53. Catalog: APB01313. | |
| Baricitinib Impurity 26 | Baricitinib Impurity 26. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(butylsulfonyl)azetidin-3-yl)acetonitrile. Molecular formula: C18H21N7O2S. Mole weight: 399.47. Catalog: APB03615. | |
| Baricitinib Impurity 27 | Baricitinib Impurity 27. Uses: For analytical and research use. Alternative Names: 2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile. CAS No. 2402776-83-2. Molecular formula: C16H17N7O2S. Mole weight: 371.12. Catalog: APB2402776832. | |
| Baricitinib Impurity 27 (Hydrochloride) | Baricitinib Impurity 27 (Hydrochloride). Uses: For analytical and research use. Alternative Names: 2-(3-(4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile hydrochloride. Molecular formula: C16H17N7O2S·HCl. Mole weight: 407.58. Catalog: APB03614. | |
Our database is helping our users find suppliers everyday.
